Industry Partners


In October, 2018 we entered into a collaborative license and co-development agreement with Clinical Laserthermia Systems (CLS) to provide next-generation navigation and laser ablation platforms for use in Spine and Neurosurgery. We also initiated an exclusive distribution agreement with CLS for the United States for its Tranberg product line for high precision ablation including interventional MR-guided procedures.

About Clinical Laserthermia Systems AB - The company is developing TRANBERG® | Thermal Therapy System for precise, safe and effective minimally invasive ablation of soft tissues including immune stimulating thermal therapy (imILT®) of solid cancerous tumors. The products have received 510(k) clearance and are CE marked. The company, which is headquartered in Lund Sweden, has subsidiaries in Germany and USA. For more information, please visit


In March 2019 we announced a collaborative agreement with Siemens Healthineers for the integration of the ‘Access-I’ software solution available on the Magnetom family of scanners worldwide with MRI Interventions’ ClearPoint® Neuro Navigation System. This advanced level of access and compatibility will facilitate faster pre-planning and peri-procedural data transfer to and from the ClearPoint System for use in both navigation and therapy procedures. Access-I is a commercial software from Siemens Healthineers that is fully compatible with Siemens’ Magnetom Scanner portfolio and allows third-party device integration through interactive remote control and data access procedures and protocols.

About Siemens Healthineers AG - Siemens Healthineers is shaping the future of Healthcare. As a leading medical technology company headquartered in Erlangen, Germany, Siemens Healthineers enables healthcare providers worldwide through its regional companies to increase value by empowering them on their journey towards expanding precision medicine, transforming care delivery, improving the patient experience, and digitalizing healthcare. Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostic, image-guided therapy, and in-vivo diagnostics. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers' ability to provide high-quality, efficient care to patients. In fiscal 2019, which ended on September 30, 2019, Siemens Healthineers, which has approximately 52,000 employees worldwide, generated revenue of €14.5 billion and adjusted profit of €2.5 billion. Further information is available at


In May 2019 we entered into a supply agreement for our neurosurgical devices supporting PTC’s current and future gene therapy programs including for AADC Deficiency, Friedreich’s Ataxia and Angelman Syndrome.

About PTC Therapuetics, Inc - PTC is a science-led, global biopharmaceutical company focused on the discovery, development and commercialization of clinically-differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need. For more information visit